Bristol-Myers Squibb Provides Update on Part 2 of CheckMate -227
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Bristol-Myers Squibb (BMY) Shares Decline After Part 2 of Phase 3 CheckMate -227 Did Not Meet Primary Endpoint
July 24, 2019 4:55 PM EDTBristol-Myers Squibb (NYSE: BMY) Shares Decline After Part 2 of Phase 3 CheckMate -227 Did Not Meet Primary Endpoint
Shares declined 4.6%
... More
